AI‐Driven Rational Design of Nanotherapeutics for Pancreatic Ductal Adenocarcinoma
{"Pancreatic":[0],"ductal":[1],"adenocarcinoma":[2],"(PDAC)":[3],"remains":[4],"a":[5],"formidable":[6],"malignancy":[7],"characterized":[8],"by":[9],"late":[10],"diagnosis,":[11],"high":[12],"recurrence":[13],"rates,":[14],"and":[15,47,54,77,94,103,120,128,145,167],"pronounced":[16],"chemoresistance.":[17],"While":[18],"nanoparticle-based":[19],"drug":[20,126],"delivery":[21],"systems":[22,97],"(NDDS)":[23],"offer":[24],"theoretical":[25],"advantages":[26],"over":[27],"conventional":[28],"therapies,":[29],"their":[30],"clinical":[31],"translation":[32],"in":[33,123,139],"PDAC":[34],"has":[35],"been":[36],"severely":[37],"limited.":[38],"The":[39],"dense":[40],"desmoplastic":[41],"stroma,":[42],"elevated":[43],"interstitial":[44],"fluid":[45],"pressure,":[46],"hypovascularity":[48],"effectively":[49],"neutralize":[50],"the":[51,63,113,146,153,173],"enhanced":[52],"permeability":[53],"retention":[55],"(EPR)":[56],"effect,":[57],"restricting":[58],"passive":[59],"nanoparticle":[60,130],"penetration.":[61],"Consequently,":[62],"therapeutic":[64],"paradigm":[65],"is":[66],"shifting":[67],"from":[68],"indiscriminate":[69],"stromal":[70,75],"depletion-which":[71],"paradoxically":[72],"accelerates":[73],"metastasis-to":[74],"normalization":[76],"immune":[78],"microenvironment":[79],"reprogramming.":[80],"This":[81],"review":[82,171],"comprehensively":[83],"evaluates":[84],"advanced":[85],"NDDS":[86,163],"platforms,":[87],"highlighting":[88],"transcytosis-triggering":[89],"active":[90],"targeting,":[91],"stimuli-responsive":[92],"carriers,":[93],"multimodal":[95],"theranostic":[96],"designed":[98],"to":[99,108],"bypass":[100],"physical":[101],"barriers":[102],"convert":[104],"immunologically":[105],"\\"cold\\"":[106],"tumors":[107],"\\"hot.\\"":[109],"Furthermore,":[110],"we":[111,134],"analyze":[112],"expanding":[114],"role":[115],"of":[116,155],"artificial":[117],"intelligence":[118],"(AI)":[119],"machine":[121],"learning":[122],"predicting":[124],"synergistic":[125],"combinations":[127],"optimizing":[129],"physicochemical":[131],"properties.":[132],"Crucially,":[133],"critique":[135],"current":[136],"epistemic":[137],"limitations":[138],"AI-driven":[140],"nanomedicine,":[141],"particularly":[142],"data":[143],"sparsity":[144],"reliance":[147],"on":[148],"2D":[149],"preclinical":[150],"models,":[151],"emphasizing":[152],"necessity":[154],"3D":[156],"patient-derived":[157],"organoid":[158],"validation.":[159],"By":[160],"integrating":[161],"rational":[162],"design":[164],"with":[165],"AI":[166],"biomarker-driven":[168],"strategies,":[169],"this":[170],"maps":[172],"essential":[174],"pathways":[175],"toward":[176],"personalized":[177],"nanotherapeutics":[178],"for":[179],"PDAC.":[180]}
Authors
- Inseon Kim (ORCID: https://orcid.org/0000-0003-1483-3890)
- Seunghun S. Lee (ORCID: https://orcid.org/0000-0002-9654-8577)
- Kaeun Chae
- Seohyun Choo
- Jueun Lee
Institutions
- Dongguk University (KR)
Publication Details
- Journal
- Medicinal Research Reviews
- Published
- 2026-09-05
- DOI
- https://doi.org/10.1002/med.70105
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Korea Institute for Advancement of Technology
- National Research Foundation of Korea